Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(559/week)
Manufacturing
(388/week)
Energy
(305/week)
Technology
(408/week)
Other Energy
(276/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Ionis Pharmaceuticals, Inc.
Feb 11, 2021
Ionis to hold 2020 financial results webcast
Jan 05, 2021
Ionis to present at 39th Annual J.P. Morgan Healthcare Conference
Dec 08, 2020
Ionis highlights achievements, commercial strategy and technology advancements at Investor Day
Dec 02, 2020
Ionis to participate in virtual fireside chat at BMO 2020 Growth and ESG conference
Dec 01, 2020
Ionis announces initiation of the global Phase 3 BALANCE study for AKCEA-APOCIII-LRX in patients with familial chylomicronemia syndrome
Dec 01, 2020
Ionis to hold virtual investor day event
Nov 30, 2020
Ionis announces AstraZeneca's initiation of the Phase 2b clinical study of its antisense medicine targeting PCSK9 to lower LDL-cholesterol
Nov 23, 2020
Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) enters development
Nov 13, 2020
Promising new data for Ionis' antisense medicine targeting PCSK9 presented at American Heart Association (AHA) Scientific Sessions 2020
Nov 09, 2020
Ionis to present at upcoming virtual investor conferences
Nov 04, 2020
Ionis reports third quarter 2020 financial results and recent business achievements
Oct 30, 2020
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product
Oct 22, 2020
Ionis' third novel antisense medicine for ALS, its first designed to treat a broad ALS population, begins clinical trial
Oct 15, 2020
Ionis antisense medicine being evaluated in an investigator-initiated clinical study of COVID-19 patients in Brazil
Oct 13, 2020
Ionis' inhaled antisense medicine demonstrates potential as a novel treatment for cystic fibrosis
Oct 01, 2020
Ionis Chief Scientific Officer Frank Bennett receives Lifetime Achievement Award from Oligonucleotide Therapeutics Society
Sep 30, 2020
Ionis treatment for Alexander disease receives orphan drug designation from U.S. FDA
Sep 03, 2020
Ionis to present at upcoming virtual investor conferences
Sep 02, 2020
New England Journal of Medicine publishes study results evaluating Ionis antisense therapy in treatment of patients with hereditary angioedema
Aug 18, 2020
Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020
Page 1
››
Latest News
May 16, 2024
Sulfur Hexafluoride (SF6) Global Strategic Industry Report 2024: Market to Reach $357 Million by 2030 from $...
May 15, 2024
Phison Introduces PASCARI Brand and Launches X200 SSD for Enterprise Market
May 15, 2024
Ross Buchmueller appointed to the USAA Board of Directors
May 15, 2024
BAE Systems to Develop Next-Generation Airborne Decoy Countermeasure
May 15, 2024
Tavant Launches New Pricing Analytics Module for its AI-powered Enterprise Analytics Platform (TMAP)
May 15, 2024
Message Broadcast Strengthens Executive Leadership Team with Key Hires
May 15, 2024
Avangrid Named Handshake Early Talent Award Winner
May 15, 2024
L3Harris CEO to Present at Bernstein Annual Strategic Decisions Conference
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events